KLF11 and pancreatic neoplasm: For instance, in pancreatic cancer cells, due to the oncogene-RAS mutation, the KLF11-mSin3a interaction that as a vital part of the “strengthen route” is disrupted by the phosphorylation of KLF11 [27].